PLoS ONE · 2010 · 63 citations · 20 references
MedicineChild HealthPediatricsChild PsychiatryPediatric EpidemiologyPediatric Mental HealthClinical TrialsPediatric Clinical TrialsChild Health QualityChildren In Clinical TrialsClinical Trials In ChildrenClinical Trials In NeonatesComparative Clinical TrialsMethodological Quality AssessmentNeonatal Trials
BACKGROUND: The objective of this study was to describe randomized controlled trials (RCTs) and controlled clinical trials (CCTs) in child health published between 1948 and 2006, in terms of quantity, methodological quality, and publication and trial characteristics. We used the Trials Register of the Cochrane Child Health Field for overall trends and a sample from this to explore trial characteristics in more detail. METHODOLOGY/PRINCIPAL FINDINGS: We extracted descriptive data on a random sample of 578 trials. Ninety-six percent of the trials were published in English; the percentage of child-only trials was 90.5%. The most frequent diagnostic categories were infectious diseases (13.2%), behavioural and psychiatric disorders (11.6%), neonatal critical care (11.4%), respiratory disorders (8.9%), non-critical neonatology (7.9%), and anaesthesia (6.5%). There were significantly fewer child-only studies (i.e., more mixed child and adult studies) over time (P = 0.0460). The proportion of RCTs to CCTs increased significantly over time (P<0.0001), as did the proportion of multicentre trials (P = 0.002). Significant increases over time were found in methodological quality (Jadad score) (P<0.0001), the proportion of double-blind studies (P<0.0001), and studies with adequate allocation concealment (P<0.0001). Additionally, we found an improvement in reporting over time: adequate description of withdrawals and losses to follow-up (P<0.0001), sample size calculations (P<0.0001), and intention-to-treat analysis (P<0.0001). However, many trials still do not describe their level of blinding, and allocation concealment was inadequately reported in the majority of studies across the entire time period. The proportion of studies with industry funding decreased slightly over time (P = 0.003), and these studies were more likely to report positive conclusions (P = 0.028). CONCLUSIONS/SIGNIFICANCE: The quantity and quality of pediatric controlled trials has increased over time; however, much work remains to be done, particularly in improving methodological issues around conduct and reporting of trials.
20
Carvedilol for Children and Adolescents With Heart Failure
Robert E. Shaddy, Mark M. Boucek, Daphne T. Hsu et al. · JAMA · 2007 · 565 citations
Risk of bias versus quality assessment of randomised controlled trials: cross sectional study
Lisa Hartling, Maria B. Ospina, Yuanyuan Liang et al. · BMJ · 2009 · 345 citations · Full text